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Neuropeptides regulate all aspects of behavior in multicellular organisms. Because of their
ability to act at long distances, neuropeptides can exert their effects beyond the conven-
tional synaptic connections, thereby adding an intricate layer of complexity to the activity of
neural networks. In the nematode Caenorhabditis elegans, a large number of neuropeptide
genes that are expressed throughout the nervous system have been identified.The actions
of these peptides supplement the synaptic connections of the 302 neurons, allowing for
fine tuning of neural networks and increasing the ways in which behaviors can be regulated.
In this review, we focus on a large family of genes encoding FMRFamide-related peptides
(FaRPs). These genes, the flp genes, have been used as a starting point to identifying flp
genes throughout Nematoda. Nematodes have the largest family of FaRPs described thus
far. The challenges in the future are the elucidation of their functions and the identification
of the receptors and signaling pathways through which they function.
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INTRODUCTION
Behavior in all animals is the output of multiple neural networks,
whose individual circuits are activated, inhibited, or modulated at
any one time by the combinatorial action of many neurotrans-
mitters. In recent years, there has been a push to determine the
neural connectome of organisms, including the human connec-
tome (Human Connectome Project). The first completed neural
connectome was that of the nematode Caenorhabditis elegans (1).
In a heroic effort and with much foresight into the usefulness of
the project, John White and collaborators embarked on decipher-
ing the entire neural circuitry and mapping all chemical synapses
and gap junctions between the 302 neurons of the C. elegans adult
hermaphrodite (1); more recently, Scott Emmons and David Hall
have initiated work on the C. elegans male neural connectome (2).
The mapping of all the synaptic connections between neurons has
been highly informative and helpful to researchers. However, the
neural connectome, while representing a large fraction of neural
network activity, underestimates the complexity of the nervous
system. Layered on top of the connectome is the action of hor-
mones and neuropeptides, whose effects can be exerted over large
distances and whose actions, therefore, are not wholly represented
by the neural connectome. Hence, hormones and neuropeptides
add considerable complexity to neural networks to affect behavior.
In C. elegans and other invertebrates, neuropeptides, which
are short sequences of amino acids, can act as primary trans-
mitters as well as neuromodulators. Most neurons in C. elegans
express at least one neuropeptide gene and in the majority of
neurons, neuropeptides are co-localized with classical small mol-
ecule transmitters, such as acetylcholine, GABA, serotonin (5-
HT), and dopamine (3, 4). Based on BLAST and bioinformatic
screening, two major families of neuropeptides emerged in
C. elegans: insulin-like peptides (ILPs) (5–9) and FMRFamide-
related peptides (FaRPs) (10–12). In addition, C. elegans also
has a large complement of non-insulin, non-FaRP neuropeptides
(NLPs), many of which have invertebrate and vertebrate orthologs
(3, 13). In this review, we will focus on the C. elegans FaRPs, which,
by definition, all share a C-terminal Arg-Phe-NH2 and which are
more commonly referred to as FLPs in C. elegans. We will describe
their processing and some of their functions, and compare the
diversity of FLPs in other nematodes.
IDENTIFICATION OF flp GENES
By cDNA library screening, bioinformatic searches, and
genome/transcriptome data mining for proteins with Arg-Phe-Gly
sequences flanked by N- and C-terminal tri-, di-, or mono-basic
residues, we and others identified 31 genes encoding FLPs in C.
elegans (10, 12). Each flp gene encodes a unique set of FLPs for a
total of 71 possible distinct FLPs (Table 1) (10, 12). Fourteen flp
genes encode a single FLP, although seven of these genes encode
multiple copies of the same FLP [flp-6 (6 copies of KSAYMRF-
NH2), 8 (3–4 copies of KNEFIRF-NH2), 9 (2 copies of KPSFVRF-
NH2), 10 (1 copy of QPKARSGYIRF-NH2), 12 (1 copy of
RNKFEFIRF-NH2), 14 (4 copies of KHEYLRF-NH2; Figure 1A),
20 (2 copies of AMMRF-NH2), 21 (1 copy of GLGRPLRF-
NH2), 22 (3 copies of SPSAKWMRF-NH2), 24 (1 copy of
VPSAGDMMVRF-NH2), 27 (1 copy of GLGGRMRF-NH2), 28 (1
copy of APNRVLMRF-NH2), 32 (1 copy of AMRNSLVRF-NH2),
33 (1 copy of APLEGFEDMSGFLRTIDGIQKPRF-NH2), and 34 (1
copy of ALNRDSVASLNNAERLRF-NH2)]. At least nine flp genes
encode non-FLP peptides [flp-1, 3 (Figure 1A), 7, 11, 20, 23, 26, 27,
and 34] and six flp genes (flp-1, 2, 8, 11, 22, and 23) are alternatively
spliced (WormBase). The organization of flp genes ranges from the
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Table 1 | Predicted FLP neuropeptides in C. elegans.
flp-1 IV flp-7 X flp-15 III flp-24 III
*SADPNFLRFG x3 *SPMQRSSMVRFG *GGPQGPLRFG *VPSAGDMMVRFG
*SQPNFLRFG x2 *TPMQRSSMVRFG *RGPSGPLRFG
*ASGDPNFLRFG SPMERSAMVRFG flp-25 III
*SDPNFLRFG SPMDRSKMVRFG flp-16 II DYDFVRFG
*AAADPNFLRFG SSIDRASMVRLG x2 *AQTFVRFG *ASYDYIRFG
*(K)PNFLRFG *GQTFVRFG
AGSDPNFLRFG flp-8 X flp-26 X
(K)PNFMRFG x3 *KNEFIRFG flp-17 IV *(E)FNADDLTLRFG
x2 KSAFVRFG *GGAGEPLAFSPDMLSLRFG
flp-2 X flp-9 IV KSQYIRFG NYYESKPY
*SPREPIRFG x2 *KPSFVRFG
LRGEPIRFG flp-18 X flp-27 II
flp-10 IV *DFDGAMPGVLRFG *(EASAFGDIIGELKGK)-
flp-3 X QPKARSGYIRFG *EMPGVLRFG GLGGRMRFG
SPLGTMRFG x3 *(K)SVPGVLRFG *pQPIDEERPIFME
*TPLGTMRFG flp-11 X *EIPGVLRFG
*EAEEPLGTMRFG *AMRNALVRFG *SEVPGVLRFG flp-28 X
NPLGTMRFG *ASGGMRNALVRFG *DVPGVLRFG *APNRVLMRFG
*ASEDALFGTMRFG *NGAPQPFVRFG
EDGNAPFGTMKFG NGAPQPFG flp-19 X flp-32 X
*SAEPFGTMRFG *WANQVRFG *AMRNSLVRFG
*SADDSAPFGTMRFG flp-12 X *ASWASSVRFG
*NPENDTPFGTMRFG *RNKFEFIRFG flp-33 I
flp-20 X *APLEGFEDMSGFLR-
flp-4 II flp-13 IV x2 AMMRFG TIDGIQKPRFG
PTFIRFG *AMDSPLIRFG AVFRMG
*ASPSFIRFG x2 *AADGAPLIRFG flp-34 I
x2 *APEASPFIRFG flp-21 V ALNRDSVASLNNAERLRFG
flp-5 X *ASPSAPLIRFG GLGPRPLRFG ADISTFASAINNAGRLRYG
*GAKFIRFG *SPSAVPLIRFG
*AGAKFIRFG *SAAAPLIRFG flp-22 I †Additional FLPs:
*APKPKFIRFG *ASSAPLIRFG x3 *SPSAKWMRFG APNRVLMRLVRF-NH2
HFYNFSSESRKPNFLRF-NH2
flp-6 V flp-14 III flp-23 III KPXPXFIRF-NH2
x6 *KSAYMRFG x4 *KHEYLRFG *VVGQQDFLRFG
NDFLRFG
EGHPEFMSQIAPP?
Chromosomal location indicated after gene name. Blue indicates common amino acids among peptides encoded by the same gene; the C-terminal glycine donates
an amide during amidation. Green indicates a non-FLP peptide. The number of copies of an encoded peptide is indicated.
*Biochemically isolated. From Rosoff et al. (14), Marks et al. (15–19), Davis and Stretton (20), Li et al. (11), Nelson et al. (10), Husson et al. (21, 22), Husson and Schoofs
(23), Husson et al. (24).
†N. Marks, A. Maule, and A. Stretton, pers. comm.
simplest at only two small exons to the largest at six exons. Simi-
larly, the FLP protein precursors are small, ranging from 66 to 184
amino acids, sizes that include the signal peptide; the bioactive
peptides vary from 5 to 24 amino acids in length (Table 1).
PROCESSING OF PRE-PRO-NEUROPEPTIDE PRECURSORS
As with other neuropeptides (25), the FLPs are derived from pre-
propeptides (Figure 1), which are large precursor molecules that
must be proteolytically cleaved and post-translationally modi-
fied to yield the active peptides (Figure 1B). The FLP precursor
molecules all have a signal peptide, which is removed to yield
the propeptide. The propeptides are then cleaved by proprotein
convertases (PCs), serine endoproteases that preferentially recog-
nize dibasic residues and cleave C-terminal to the basic residues
(26). In C. elegans, PCs also cleave after tribasic and monobasic
residues and very rarely, after a non-basic residue. Of the FLP
precursor molecules, including different isoforms encoded by one
gene, there are 184 instances of FLP sequences flanked by basic
amino acids (Table 2). Seventy-one percent of the FLPs are flanked
by the typical dibasic residues, of which the majority (83%) are
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FIGURE 1 | Processing of neuropeptide precursor molecules. (A)
Representative FLP precursor molecules that contain one FLP peptide
(FLP-10), multiple copies of the same FLP peptide (FLP-14), multiple distinct
FLP peptides (FLP-3), and multiple distinct FLP peptides and multiple copies
of the same FLP (FLP-16) are shown. (B) Proteolytic pathway of the FLP-16
precursor molecule to yield the active FLP-16 peptides.
Lys-Arg, and 29% are flanked by monobasic residues of which Arg
is the most common residue (70%). Five FLP peptides are directly
followed by a stop codon and one FLP peptide has an unusual
non-basic flanking residue (Ala).
There are four genes encoding PCs in C. elegans: kpc-1, egl-
3/kpc-2, aex-5/kpc-3, and bli-4/kpc-4; with the exception of aex-
5/kpc-3, all are alternatively spliced to yield isoforms that differ
at the C-terminus [(27, 28); WormBase], suggesting that differ-
ent isoforms may have different substrate targets or preferences.
Mutant alleles of all the PC genes have been isolated (27–31).
By mass spectrometry (MS) analysis of neuropeptide profiles,
the major PC that cleaves FLP propeptides is EGL-3/KPC-2 (22),
whose mammalian ortholog is proprotein convertase 2 (PC2) (32).
The number of isolated FLP peptides is significantly decreased
in egl-3/kpc-2 mutants compared to in kpc-1, aex-5/kpc-3, and
bli-4/kpc-4 mutants (22). However, the biochemical data also
indicate that besides EGL-3/KPC-2 other PCs cleave propeptides
(22). Furthermore, using an antibody that only recognizes mature
FLPs, anti-FMRFamide immunoreactivity was detected in egl-3
mutants, suggesting that other PC2s function in neuropeptide
processing in C. elegans (33). egl-3 is widely expressed in the
nervous system and acts within post-Golgi secretory vesicles
(32). Knockout of egl-3 PC2 causes several defects, including in
egg-laying (30) and body mechanosensation (32).
The minor PCs also have the capability to cleave neuropeptide
precursors. kpc-1 encodes a PC similar to mammalian furin (28)
and is widely expressed in the nervous system and epithelial cells
(34). kpc-1 PC mutants show slight uncoordination and slowed
growth (28) and have defects in the dendritic remodeling of the
IL2 neurons during dauer formation and nictation (34). While
the dendritic remodeling defects may be due to lack of cleavage of
semaphorins or TGFβ substrates (34), the nictation defects may
be due to lack of cleavage of neuropeptide precursors to yield
active peptides that regulate nictation (35). aex-5/kpc-3 mutants
show a defect in the defecation motor pattern (31). Furthermore,
knockdown of aex-5/kpc-3 by RNA-mediated interference (RNAi)
feeding gives a low rate of embryonic lethality (36), suggesting
other essential substrates for AEX-5/KPC-3. The genomic organi-
zation of aex-5/kpc-3 is slightly unusual because it is part of an
operon with unc-54, which encodes a muscle myosin heavy chain
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Table 2 | Residues flanking FLP*.
Basic residues No. sites
KRR 1
KR 108
RK 10
KK 9
RR 3
R 37
K 16
Non-basic residue
A† 1
Stop codon 5
*Includes all alternative transcripts.
†A non-FLP peptide encoded by flp-27 is also flanked by an A.
Peptides encoded by all flp transcripts.
(28); the regulation of the operon would predict that aex-5/kpc-3
is expressed only in muscle, similar to unc-54 myosin. However,
intestinal specific expression of aex-5/kpc-3 can rescue the defec-
tion motor program in aex-5/kpc-3 mutants, suggesting that the
intestine also expresses aex-5/kpc-3 (37). bli-4/kpc-4 encodes a
furin-like protease that is expressed in neurons, hypodermal cells,
vulval muscles, and the intestine; loss of bli-4/kpc-4 results in late
embryonic lethality (27). Although DPY-5 is a procollagen that
must be cleaved by BLI-4/KPC-4 for proper adult cuticle formation
(38), BLI-4/KPC-4 must have other substrates, currently uniden-
tified, during embryogenesis. The relevance of the different PC
isoforms is unknown, but may relate to substrate specificity.
The PC2s themselves are also synthesized as precursor mol-
ecules that must be proteolytically cleaved to become activated
and transported (39). SBT-1 is the C. elegans neuroendocrine 7B2
ortholog (40) that presumably cleaves pro-EGL-3/PC2 for its acti-
vation. In high pressure liquic chromatography (HPLC)-MS iso-
lations, 29 FLPs were isolated from extracts of sbt-1/7B2 mutants
compared to 53 FLPs isolated from wild-type extracts, suggesting
that loss of sbt-1 interferes with neuropeptide maturation (23).
sbt-1/7B2 mutants also showed resistance to the effects of aldicarb
(40), an acetylcholinesterase inhibitor that causes paralysis in C.
elegans (41).
After cleavage by the PCs, the C-terminal basic residues are
removed by the action of carboxypeptidase E (CPE), which cleaves
N-terminal to the basic residue(s). In C. elegans, one CPE ortholog
is egl-21, which is expressed widely in the nervous system (33). Loss
of egl-21 CPE results in defects in egg-laying (30), locomotion,
and defecation and decreased FMRFamide-like immunoreactivity
and aldicarb sensitivity (33). Because residual FMRFamide-like
immunoreactivity is present in egl-21 CPE mutants (33), other
carboxypeptidases must also function to process peptide inter-
mediates. There are two other carboxypeptidases with similar-
ity to CPE and carboxypeptidase D (33): CPD-1/F59A3.1 and
CPD-2/T27A8.11. Knockdown of cpd-2/T27A8.1 had no phe-
notype, whereas knockdown of cpd-1 by RNAi showed variable
1http://www.wormbase.org
uncoordination and larval lethality (42). Elucidation of cpd-1 and
cpd-2 function in neuropeptide processing awaits future mutant
analysis.
To prolong their effects, many neuropeptides are post-
translationally modified to prevent their immediate degradation.
In the case of the FLPs, the peptides are amidated and this ami-
dation is required for the bioactivity of the peptide (43). The
amide at the C-terminus of each mature FLP is donated by the
C-terminal glycine. In mammals, amidation occurs as the result
of two sequential enzymatic steps from a bifunctional protein
peptidylgylcine-α-amidating monooxygenase (PAM): the peptide
is subjected to the action of a peptidylgylcine-α-hydroxylating
monooxygenase (PHM), followed by the action of a peptidyl-
α-hydroxyglycine α-amidating lyase (PAL) (44, 45). By con-
trast, C. elegans has two independent enzymes: PAMN-1/ T19B4.1
and PGAL-1/F21F3.1 have similarity to PHM and PAL, respec-
tively, and could function in neuropeptide amidation [(46);
WormBase].
After release, inactivation of neuropeptide signaling is regu-
lated by their proteolytic cleavage by the class of neprilysin (NEP)
zinc metallopeptidases (47). In C. elegans, NEP activity cleaves
the amino group of hydrophobic amino acids; for instance, FLP-1
(SDPNFLRF-NH2) is cleaved at multiple sites (e.g., NF, FL, and
RF), each including the Phe residue (48). At least 20 NEP-encoding
genes are present in C. elegans; 10 of these are known to be
expressed (48–50). nep-1 is expressed in pharyngeal cells and
a single head neuron (51), suggesting that NEPs are active at
different synapses. A nep-1 knockout showed an uncoordinated
phenotype; in addition, in isolated pharyngeal preparations, nep-
1 mutants showed decreased basal activity (51). Which, if any,
of these NEP genes are relevant to peptide processing is still
unknown.
PACKAGING AND RELEASE OF FLPs
The processing of neuropeptide precursor molecules into bioactive
peptides starts in the endoplasmic reticulum (ER), when the signal
peptide is first removed. Subsequent cleavages of the propeptide
and post-translational modifications of the cleaved peptides occur
in the ER and Golgi network or as the vesicle, which in the case of
neuropeptides is large, dense core vesicles (DCVs), is transported
to the nerve terminal. In C. elegans transport of DCVs to the nerve
terminals is dependent on UNC-104/KIF1A/kinesin-3 (33, 52, 53)
and UNC-116/kinesin-1 (53).
Small molecule transmitters and neuropeptides are packaged
into distinct vesicles, small, clear synaptic vesicles (SVs) versus
large, DCVs, respectively. Calcium triggers the release of their
contents with a latency of 4.5 ms after the peak of an action poten-
tial for SVs or 16.7 ms for DCVs, which show better release after
repeated or prolonged stimulation (54). In addition, the contents
of the vesicles are significantly different; one SV releases about
4,700 transmitter molecules with a time constant of decay of
transmitter discharge of 260µs, while one DCV releases about
18,000 molecules with a time constant of 1.6 ms (54). DCVs
are marked by the presence of IDA-1/IA-2/phogrin, which is a
receptor protein tyrosine phosphatase found specifically on DCVs
and which regulates levels of phosphatidylinositol phospholipids
(PIPs) (55, 56). Regulated release of either type of vesicle is a
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multi-step process: vesicle docking, priming, fusion, and release.
DCVs are primarily found in C. elegans axons and not in cell
somas; activity of the UNC-43 CaMKII regulates DCV exocytosis
from the axon rather than the cell soma (57). The core SNARE
complex, which includes vesicular SNB-1/synaptobrevin-1 (v-
SNARE) and plasma membrane proteins RIC-4/SNAP-25 and
UNC-64/syntaxin (t-SNAREs), is essential for this process and
interacts with a number of other proteins, some specific to DCVs,
to facilitate vesicular release (58). Presumably, v-SNARE SNT-
1/synaptotagmin (59) has a similar function with DCVs and acts
as a calcium sensor. Both types of vesicles also require the cyto-
plasmic protein UNC-18 for vesicular release; UNC-18/Munc-18
has multiple functions: (1) it helps in the efficient trafficking
from the ER and anterograde transport of UNC-64/syntaxin (60);
(2) it binds UNC-64/syntaxin and mediates the conformational
switch of UNC-64/syntaxin from a closed to open state to allow
SNARE complex assembly, thereby priming the vesicle (61–63);
and (3) it allows vesicle and plasma membrane fusion (62). Unlike
SVs that are docked and released from active zones, DCVs are
released at sites distinct from active zones (64). These DCV dock-
ing sites may be determined by the cytoplasmic protein RIC-7,
which is a nematode-specific protein with no known homolo-
gies (65). UNC-31/CAPS, a calcium-dependent activator protein
that contains a DCV-binding domain and pleckstrin-homology
domain, serves as a bridge between DCVs and the plasma mem-
brane (66, 67) to promote DCV docking and release (64, 68, 69).
UNC-13, which promotes SNARE complex assembly (69, 70),
and PKC-1 both contain C1 domains that bind phorbol esters
to regulate vesicular release, although PKC-1 is only involved in
DCV release (69). UNC-13/Munc13 stabilizes the open confor-
mation of syntaxin to promote vesicle priming and this activity
is antagonized by TOM-1/tomosyn, which associates with UNC-
64/syntaxin and RIC-4/SNAP-25 to form an inhibitory SNARE
complex (71) and prevent DCV release (68). Unlike small molecule
transmitters, neuropeptides are not recycled and excess neuropep-
tides are cleared from the synaptic regions by degradation (see
above); new neuropropeptides must be synthesized de novo in the
cell body, processed and packaged into DCVs, and transported to
the nerve terminals.
ISOLATION OF FLPs AND EXPRESSION PATTERNS
Among the 31 flp genes, there are 71 predicted FLPs. The ini-
tial isolation of FLPs was through laborious extracts from grams
worth of animals (14–19, 21). Fortunately, the advent of new
technologies with high pressure liquid chromatography in tan-
dem with MALDI-TOF mass spectrometry have greatly decreased
the amount of starting materials necessary for peptidomic studies
and increased the resolution of peptide identities. Hence, micro-
gram amounts of animals are now sufficient to isolate even low
abundance peptides. The group of Liliane Schoofs has taken on
the challenge to decipher the FLP peptidome in C. elegans and
other nematodes (22, 24). Fifty-four of the 71 predicted FLPs rep-
resenting 25 of the 31 flp genes have now been isolated (Table 1)
(22, 24). However, there are also three FLPs, APNRVLMRLVRF-
NH2, HFYNFSSESRKPNFLRF-NH2, and KPXPXFIRF-NH2, that
have been biochemically isolated, but the corresponding gene has
not been identified (N. Marks, A. Maule, and A.O. Stretton, pers.
comm.). These results suggest that most, if not all, predicted FLPs
are produced and additional flp genes have yet to be identified.
Given that many of the peptides encoded by one gene are highly
similar, we predict that these peptides have slightly different
binding affinities to receptors to allow fine tweaking of a circuit.
For instance, flp-18 encodes six distinct FLPs that share a common
C-terminal PGVLRF-NH2; NMR analysis of two of the peptides
DGDGAMPGVLRF-NH2 and EMPGVLRF-NH2 revealed that the
N-terminal aspartates of DGDGAMPGVLRF-NH2 form long-
range electrostatic interactions with the C-terminal arginines,
thereby forming a loop that decreases peptide binding to one of its
receptors, NPR-1 (72). Similarly, other N-terminal extensions can
form secondary structures that decrease the affinity of the peptide
to its receptors, thereby modulating the biological effects of the
peptides.
cDNAs from all flp genes have been isolated, indicating that
all flp genes are expressed [(4, 10, 73, 74); WormBase]. Because
FLPs are relatively small, ranging from 5 to 24 amino acids, and
all share a C-terminal Arg-Phe-NH2 motif, making antibodies
against specific FLPs have been difficult. A general anti-FaRP
antiserum that recognizes FaRPs encoded by multiple flp genes
showed that roughly 10% of the neurons were immunoreac-
tive (75). This figure, however, appears to grossly underestimate
the widespread expression of the flp genes. Using transcriptional
reporters, over 50% of the nervous system was found to express
one or more flp genes (4, 76–78). Transcriptional reporters, how-
ever, have many inherent caveats, such as incorrect/incomplete
promoter regions used or intronic sequences with regulatory
elements missing; in addition, researchers injecting similar con-
structs have sometimes reported different expression patterns
(4, 77). Using a monoclonal antibody specific for FLP-8 (79,
80), we showed that the immunoreactivity pattern matched that
of the reporter expression pattern, suggesting that transcrip-
tional reporters can reflect protein expression patterns. Although
each flp gene is expressed in a distinct set of neurons, there
is considerable overlap in the expression pattern of the differ-
ent flp genes and a single neuron can show a wide diversity
of flp expression. For instance, the chemosensory neuron ASE
and oxygen-sensor URX express five and four flp genes, respec-
tively (4). In addition, most flp genes are expressed in neurons
that also express a small molecule transmitter. Some flp genes
are also expressed in non-neuronal cells, such as the intestine
or gonad (4, 77). The complex flp expression pattern allows
exceptionally intricate modulation of neural networks to generate
behavior.
FUNCTION OF FLPs IN C. ELEGANS
FLP neuropeptides have been shown to function in various behav-
iors in C. elegans (Table 3). A common functional modality among
FLPs is that these neuropeptides appear to inhibit circuit activity
in most, but not all, behaviors tested. Pharmacological applica-
tion of FLPs, however, shows that FLPs also has excitatory effects
(Table 3).
LOCOMOTION
Wild-type animals move in a sinusoidal waveform on a solid sur-
face and initiate swimming in liquid. flp-1 mutants displayed
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Table 3 | Function of FLP Neuropeptides in C. elegans.
flp gene Phenotypes in mutants or by RNAi Phenotypes due to
overexpression
Pharmacology of FLPs
on pharynx
flp-1 Loopy waveform (1); suppressed paralysis due to
increased levels of dopamine (2); enhanced convulsive
locomotion and aldicarb hypersensitivity in synergy with
flp-18 (3); decreased entry into the active phase of
egg-laying (4)
Flattened waveform (1) Decreased pharyngeal activity at 1 µM (5, 6)
flp-2 Increased pharyngeal activity at 1µM (6)
flp-3 Decreased pharyngeal activity at 1µM (5, 6)
flp-4 Increased pharyngeal activity at 1µM (6)
flp-5 Increased pharyngeal activity at 1µM (5, 6)
flp-6 Increased pharyngeal activity at 1µM (5, 6)
flp-8 Increased repetitive turning during male mating (7) Increased pharyngeal activity at 100 nM (5, 6)
flp-9 Decreased pharyngeal activity at 1µM (5, 6)
flp-10 Increased repetitive turning during male mating (7) Inhibits egg-laying (8)
flp-11 Decreased pharyngeal activity at 100 nM (5, 6)
flp-12 Increased repetitive turning during male mating (7)
flp-13 Decreased pharyngeal activity at 100 nM (4, 5)
flp-14 Increased pharyngeal activity at 1µM (5, 6)
flp-15 Decreased pharyngeal activity at 1µM (5, 6)
flp-16 Decreased pharyngeal activity at 1µM (5, 6)
flp-17 Inhibits egg-laying (8) Increased pharyngeal activity at 100 nM (6)
flp-18 Decreased odor response, increased reversals after
starvation, enhanced dauer formation in daf-7 TGFβ
mutants, reduced oxygen consumption, increased
intestinal fat storage (9); enhanced locomotory activity of
npr-1(g320) mutants during lethargus (10)
flp-19 Decreased pharyngeal activity at 1µM (4, 5)
flp-20 Loss of massed training-induced memory for tap
habituation and decreased number of synaptic vesicles
(11); increased repetitive turning during male mating (7)
flp-21 Blocked hypoxia-induced 5-HT stress signals from the
pharynx to head neurons (12); enhanced locomotory
activity of npr-1(g320) mutants during lethargus (10);
increased thermal thresholds for heat avoidance (13);
displayed aggregation behavior (14)
Decreased pharyngeal activity at 1µM (5, 6)
flp-22 Increased pharyngeal activity at 1µM (6)
5-HT= serotonin; 1, Nelson et al. (76); 2, Wani et al. (81); 3, Stawicki et al. (82); 4, Waggoner et al. (83); 5, Rogers et al. (84); 6, Papaioannou et al. (85); 7, Liu et al.
(86); 8, Ringstad and Horvitz (77); 9, Cohen et al. (87); 10, Choi et al. (88); 11, Li et al. (89); 12, Pocock and Hobert (90); 13, Glauser et al. (91); 14, Rogers et al. (78).
an exaggerated waveform on a solid surface; conversely, over-
expression of flp-1 caused a flattening of the waveform and
extreme sluggishness, suggesting that flp-1 modulates the loco-
motory circuits (76). dat-1 encodes a dopamine transporter and
mutations in dat-1 caused paralysis due to increased synaptic
dopamine concentration (92). Chase and coworkers showed that
a flp-1 mutation fully suppressed this locomotion defect of dat-1
mutants (81). Although the exact mechanism has not been eluci-
dated, these results further indicate a role of flp-1 in locomotory
circuits (76).
ACR-2 is a nicotinic acetylcholine receptor subunit expressed
in cholinergic motoneurons (93). acr-2 gain-of-function (gf)
mutants exhibited excitation–inhibition imbalance due to an
increase in cholinergic excitation and a decrease in GABAergic
inhibition in the locomotory circuit, resulting in spontaneous
convulsive behavior and increased aldicarb sensitivity (93). Loss
of egl-3 PC2 decreased GABAergic inhibition and enhanced the
convulsion phenotype of acr-2(gf), suggesting that neuropeptides
were involved (82). After testing multiple neuropeptide mutants,
flp-1; flp-18 double mutants but not single mutants, were iden-
tified as enhancing convulsive locomotion and aldicarb hyper-
sensitivity of acr-2(gf) by further reducing GABAergic inhibition
(82). In addition, acr-2(gf) mutants showed increased expres-
sion of flp-18 in the ventral cord cholinergic B-type motoneurons
and overexpression of flp-18 decreased convulsion phenotype of
acr-2(gf) (82). NPR-1 and NPR-5 G protein-coupled receptors
(GPCRs) appeared to mediate the action of FLP-18 in acr-2 (gf)
mutants (82). These results indicate that flp-1 and flp-18 play
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important roles in suppressing overexcitation of the locomotory
circuit.
EGG-LAYING
C. elegans egg-laying behavior is regulated by the actions of both
small molecule neurotransmitters, such as acetylcholine and 5-HT,
and neuropeptides (94). The HSN and VC4/5 serotoninergic neu-
rons control the temporal switch between active/inactive states of
egg-laying; during the active phase, release of acetylcholine trig-
gers the egg-laying event (95). flp-1 functions in parallel with
serotonin to promote entry into the active phase of egg-laying
(83). A different peptidergic circuit regulating egg-laying behav-
ior was revealed by analysis of egl-6 mutants, which were isolated
on the basis of their egg-laying defects (30). EGL-6 is a GPCR;
a gain-of-function mutation or overexpression of egl-6 exclu-
sively in the HSN motoneurons inhibited egg-laying, while egl-6
deletion mutants did not exhibit egg-laying defects (77). How-
ever, egl-6 deletion mutants fully suppressed egg-laying defects
caused by overexpression of flp-10 or flp-17 (77). Surprisingly,
the effects of the FLP-10 peptide were conferred by expression
in non-neuronal cells, including vulval cells and spermatheca, as
well as the CO2-sensing BAG neurons, whereas flp-17 appeared to
function primarily in the BAG neurons (77). The FLP-10/FLP-17
peptidergic circuit acted redundantly with a cholinergic circuit dis-
tinct from HSN/VCs to inhibit egg-laying (77). Using the Xenopus
oocyte heterologous system, FLP-10 and FLP-17 were verified as
cognate ligands for EGL-6 GPCR (77).
METABOLISM
de Bono and coworkers found that flp-18 deletion mutants
showed a multitude of defects, including decreased odor response,
increased reversals and turns after 1 h of starvation, enhanced
dauer formation in daf-7 TGFβ mutant background, reduced
oxygen consumption, and increased intestinal fat storage (87).
These flp-18 phenotypes were rescued by expression of flp-18
in the AIY interneurons (or additionally RIG interneurons for
the fat phenotype), which are major synaptic targets of multiple
chemosensory neurons, indicating that the AIY neurons may inte-
grate and process food information to determine release of FLP-18
(87). FLP-18 activated two GPCRs, NPR-4 and NPR-5, in Xeno-
pus oocytes; furthermore, activation of NPR-4 in the intestine and
NPR-5 in a set of chemosensory neurons mediated fat storage,
activation of NPR-4 in the AVA and RIV interneurons mediated
reversals and turns, and activation of NPR-5 in the ASJ chemosen-
sory neurons mediated dauer formation (87). Fat storage was also
increased in two other NPY-like receptor mutants, npr-1 or npr-7 ,
suggesting additional roles of non-FLP-18 neuropeptides in fat
metabolism (87).
STRESS RESPONSES
Pocock and Hobert noticed that hypoxic stress increased levels
of serotonin (5-HT) in a subset of gustatory neurons (ASG and
ADF) of C. elegans via direct regulation by the hypoxia-inducible
transcription factor HIF-1 and enhanced response to NaCl (90).
Serotonin released from the ASG and ADF neurons activated the
M4 pharyngeal motoneuron via its SER-7 5-HT receptor; acti-
vation of M4 resulted in the release of the FLP-21 peptide to
relay these hypoxia-induced 5-HT signals from the pharynx to
NPR-1-expressing neurons in the head (AQR, PQR, and URX),
which may act upstream of the gustatory circuit (90). Thus,
FLP-21 and its receptor NPR-1 play roles in transmitting stress
signals.
AGGREGATION
The wild-type laboratory strain N2 var. Bristol displays soli-
tary feeding behavior (96). However, under stressful conditions,
such as high population density, low food, or low O2 concen-
tration, animals will aggregate (96–98). In addition, a mutation
in the Bristol npr-1 GPCR gene that corresponded to an NPR-
1 isoform found in many naturally isolated wild strains caused
aggregation even under non-stressful conditions, indicating that
low activity of NPR-1 GPCR may represent stress-related behav-
ioral states (96, 99, 100); expression of npr-1 in the AQR, PQR,
and oxygen-sensor URX neurons regulates aggregation behavior
(101). Animals lacking FLP-21, a cognate ligand of NPR-1 GPCR,
also displayed aggregation behavior, providing genetic evidence
for interactions between FLP-21 and NPR-1 (78, 102). Recently,
Bargmann, Sengupta, and coworkers found a“hub-and-spoke”cir-
cuit motif that generates behavioral differences depending upon
NPR-1 activity (103, 104). In this circuit, the RMG command
interneuron/motoneuron, which also expresses npr-1 (101), serves
as the hub of seven spoke neurons, including two pheromone-
sensing neurons ASK and ADL and an oxygen-sensing URX,
which are connected to the RMG hub via gap junctions; high
RMG activity is required for aggregation behavior (103, 104).
The ASK neuron is involved in male attraction and hermaph-
rodite repulsion at low and high concentrations of pheromone,
respectively (105). High NPR-1 activity in solitary N2 hermaph-
rodites resulted in decreased RMG activity, leading to an avoidance
response due to the enhanced ADL (repulsion) and reduced ASK
(attraction) pheromone response (103, 104). Conversely, low or
absent NPR-1 activity resulted in increased RMG activity, lead-
ing to an increased ASK–RMG mediated attraction and decreased
ADL mediated repulsion, resulting in hermaphrodites being neu-
tral to pheromone (103, 104). Thus, NPR-1 signaling in RMG
regulates its activity level to integrate environmental signals, such
as pheromones and oxygen.
SLEEP-LIKE BEHAVIOR
During each of the four larval molts, C. elegans exhibits a sleep-
like behavioral state during a period called lethargus, during which
wild-type animals show reduced sensory and motor activity and
feeding behaviors (106). By contrast, npr-1 GPCR mutants exhib-
ited increased locomotive activity compared to that of quiescent
wild-type animals; this activity was further enhanced in flp-18 or
flp-21 single or double mutants (88). FLP-18/21 activation of NPR-
1 signaling in the RMG hub-and-spoke interneuron was found to
decrease sensory activity of the ASK sensory neurons, resulting in
decreased PDF-1 secretion from the ASK neurons (88). Decreased
PDF-1 secretion led to decreased activation of the PDF-1 receptor
in mechanosensory neurons and muscles, resulting in decreased
arousal (88). Thus, flp-18 and flp-21 have roles in decreasing
neuronal and circuit activities underlying lethargus.
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LEARNING AND MEMORY
C. elegans have been shown to habituate to mechanical stimuli gen-
erated by tapping the worm plate; repeated tap stimulation caused
decremented responses to taps (107). Massed training-induced
memory for tap habituation lasted at least 12 h (89). This 12-h
memory retention of tap habituation training was abolished in
flp-20 mutants and the increased number of SVs in mechanosen-
sory neurons after massed training was also reduced in flp-20
mutants, indicating that FLP-20 is required for the 12-h mem-
ory retention (89). Since flp-20 was expressed in and acted in the
mechanosensory neurons, FLP-20 may regulate the number of
DCVs in mechanosensory neurons via a feedback circuit (89).
HEAT AVOIDANCE
Goodman and coworkers developed new assays to identify genes
involved in heat avoidance (91). Mutations in either flp-21 or npr-1
were found to increase thermal thresholds of heat avoidance. These
effects may be due to FLP-21 activation of the RMG interneurons
to decrease thermal thresholds (91).
MALE MATING
During mating, males undergo a stereotypic series of movements
that includes hermaphrodite contact, backing, turning, locating
the vulva, spicule insertion, and sperm transfer (108, 109). The
male tail contains many specialized ray neurons that function in
concert with core neurons for efficient male mating. In particular,
glutamatergic mechanosensory neurons are required indepen-
dently of ray neurons for turning behavior (86). In addition, loss
of flp-8, 10, 12, and 20, all of which are expressed in all or subsets
of the mechanosensory neurons (4), increased repetitive turning
behavior, suggesting that these FLPs are necessary for the accurate
timing of turning (86).
PHARYNGEAL PHARMACOLOGY
Holden-Dye’s group has made excellent use of a dissected pha-
ryngeal preparation that contains the pharynx and nerve ring;
the pharyngeal musculature has myogenic properties that can
be stimulated with 500 nM serotonin (84). By recording from
the pharyngeal muscle with either an intracellular electrode or
a suction pipette, the group found that numerous FLP peptides
increased (FLP-17 and 8 at 100 nM; FLP-2, 4, 5, 6, 14, and 22 at
1µM) or decreased (FLP-11 and 13 at 100 nM; FLP-1, 3, 9, 15, 16,
19, and 21 at 1µM) pharyngeal activity (84, 85). Several of the
flp genes with bioactive peptides are expressed within pharyngeal
neurons, but many of the genes encoding the bioactive peptides are
expressed in neurons outside the pharyngeal system (4). Whether
the peptides are acting directly on pharyngeal muscle or indi-
rectly via other neurons remains to be determined. In addition,
because some of the peptides were bioactive only at high con-
centrations, the physiological roles of the peptides await further
confirmation.
IDENTIFYING G PROTEIN-COUPLED RECEPTORS THROUGH
WHICH FLPs SIGNAL
With one exception (110), neuropeptides signal through GPCRs.
In C. elegans, there are an estimated 1,100 GPCRs (111) of which
most have been classified as chemoreceptors and 50–125 are likely
to correspond to neuropeptide GPCRs (111, 112). Knocking down
activity of a subset of the identified neuropeptide receptors sug-
gest that signaling through these receptors affect reproduction and
locomotion (113).
A current initiative by several labs has been to de-orphanize
the GPCRs by identifying their respective ligand(s) and determin-
ing the pathways in which they function. This task is daunting in
any system, because GPCRs are promiscuous and can bind more
than one ligand; similarly, neuropeptides are also promiscuous
and one peptide may bind multiple GPCRs with different affini-
ties. Whether these differing binding affinities reflect a biological
function, whereby activation by a specific peptide may only occur
after low or high frequency stimulation, or are an artifact of the
experimental system remains to be clarified.
Several heterologous systems have been used to de-orphanize
FLP receptors: expression of receptors in Xenopus laevis oocytes
or in cell lines and use of different signaling readouts, includ-
ing whole cell voltage-clamp, GTPγS binding, cAMP levels, and
calcium indicators, to determine receptor activation. The EC50
(concentration which produces 50% maximal activation) varies
substantially among the different readouts (nanomolar to micro-
molar), suggesting different sensitivity among the readout systems.
These studies have revealed that as with vertebrate and other
invertebrate neuropeptide receptors, C. elegans FLP receptors are
generally activated by multiple FLPs, which may be encoded by the
same or,more likely,distinct flp genes (Table 4). FRPR-18/T19F4.1,
is the only receptor identified thus far that is activated by peptides
encoded by only one flp gene, flp-2, with a physiological EC50
(114). Most receptors are activated by peptides encoded by mul-
tiple flp genes. For instance, NPR-3/C10C6.2 was activated at an
EC50 in the nM range by both peptides encoded by flp-15 (115)
and the single flp-21 peptide, which all share a C-terminal PLR-
Famide (116). FRPR-3/C26F1.6 was activated by one FLP-11 and
one FLP-7 peptide, both of which share a C-terminal VRFamide,
while other closely related FLP-7 and FLP-11 peptides did not
activate the receptor (117). EGL-6/C46F4.1 was activated by two
C-terminally related peptides (YIRFamide), FLP-10, and FLP-17
(77). Several receptors can be activated by a large number of FLP
peptides that do not appear to share structural similarities except
for the C-terminal RFamide: NPR-22/Y59H11AL.1 binds 15 pep-
tides encoded by six flp genes (flp-1, 7, 9, 13, 11, and 22) with an
EC50 ranging from 25 nM to 5µM (116, 118), NPR-4/C16D6.2
binds 13 peptides encoded by seven flp genes (flp-1, 3, 4, 11, 14,
15, and 18) with an EC50 ranging from 5 nM to >10µM (116),
and NPR-11/C25G6.5 binds eight FLP peptides encoded by five
genes (flp-1, 5, 14, 18, and 21) with an EC50 ranging from 1 nM
to 8µM (116). Despite being able to activate receptors at high
concentrations (e.g., EC50 > 10µM), such peptides may not be
physiological ligands. For instance, FLP-1 activates multiple recep-
tors, but all at an EC50 that is unlikely to be physiological; hence,
the FLP-1 receptor has yet to be identified. One receptor, CKR-2,
has been found to bind both FLP and non-FLP peptides. CKR-2
binds NLP-12 and NLP-13 at high affinity (nanomolar range), but
also binds a FLP-1 peptide at low affinity (>10µM) (119). The
complexity with which the peptides binds receptors and the recep-
tors bind peptides suggests that behaviors can be subtly refined by
modulating peptide levels.
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Table 4 | Receptors that bind FLP peptides.
Activates/binds receptor
Receptor Cosmid EC50 in nM range EC50 in mM range (EC50>10 mM)
NPR-1 C39E6.6 FLP-18 (EMPGVLRFa,
DFDGAMPGVLRFa,
SVPGVLRFa, EIPGVLRFa)
FLP-21 (GLGPRPLRFa)
FLP-18 (SEVPGVLRFa,
DVPGVLRFa)
NPR-3 C10C6.2 FLP-15 (GGPQGPLRFa,
RGPSGPLRFa)
FLP-21 (GLGPRPLRFa)
NPR-4 C16D6.2 FLP-4 (ASPFIRFa)
FLP-18 (DVPGVLRFa,
(K)SEVPGVLRFa,
SVPGVLRFa,
DFDGAMPGVLRFa,
EIPGVLRFa)
FLP-1 (KPNFLRFa)
FLP-3 (SPLGTMRFa,
SAEPFGTMRFa)
FLP-11 (NGAPQPFVRFa)
FLP-15 (GGPQGPLRFa)
NPR-5 Y58G8A.4 FLP-18 (DVPGVLRFa,
(K)SEVPGVLRFa,
SVPGVLRFa,
DFDGAMPGVLRFa,
EIPGVLRFa)
FLP-21 (GLGPRPLRFa)
FLP-1 (KPNFLRFa,
SQPNFLRFa)
FLP-3 (SPLGRTMRFa,
SAEPFGTMRFa,
SADDSAPFGTMRFa,
EDGNAPFGTMRFa)
NPR-6 F41E7.3 FLP-18 (DVPGVLRFa,
(K)SVPGVLRFa)
FLP-21 (GLGPRPLRFa)
NPR-10 C53C7.1 FLP-3 (SPLGTMRFa,
SAFPFGTMRFa,
SADDSAPFGTMRFa,
ASEDALFGTMRFa,
EDGNAPFGTMRFa,
EAEEPLGTMRFa)
FLP-18 (SVPGVLRFa)
FLP-18 (KSVPGVLRFa,
DVPGVLRFa,
SEVPGVLRFa,
DFDGAMPGVLRFa,
EIPGVLRFa)
NPR-11 C25G6.5 FLP-18 (SVPGVLRFa)
FLP-21 (GLGPRPLRFa)
FLP-1 (KPNFLRFa)
FLP-5 (AGAKFIRFa)
FLP-14 (KHEYLRFa)
FLP-18 (KSVPGVLRFa)
NPR-22 Y59H11AL.1 FLP-7 (SPMERSAMVRFa) FLP-1 (KPNFMRYa)
FLP-7 (TPMQRSSMVRFa,
SPMQRSSMVRFa,
SPMDRSKMVRFa)
FLP-9 (KPSFVRFa)
FLP-11 (AMRNALVRFa,
NGAPQPFVRFa)
FLP-13 (AADGAPLIRFa,
ASPSAPLIRFa,
SPSAVPLIRFa,
ASSAPLIRFa,
SAAAPLIRFa)
FLP-22 (SPSAKWMRFa)
FRPR-3 C26F1.6 FLP-7 (TPMQRSSMVRFa)
FLP-11 (AMRNALVRFa)
FLP-7 (SPMQRSSMVRFa,
SPMERSAMVRFa)
FRPR-18 T19F4.1 FLP-2 (SPREPIRFa,
LRGEPIRFa)
FLP-10 (QPKARSGYIRFa)
FLP-11 (AMRNAVLRFa)
FLP-14 (KHEYLRFa)
(Continued)
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Table 4 | Continued
Activates/binds receptor
Receptor Cosmid EC50 in nM range EC50 in mM range (EC50>10 mM)
EGL-6 C46F4.1 FLP-10 (QPKARSGYIRFa)
FLP-17 (KSQYIRFa,
KSAFVRFa)
CKR-2 Y39A3B.5 NLP-12 (DYRPLQFa,
DGYRPLQFa)
FLP-1 (SADPNFLRFa)
NLP-13 (pQPSYDRDIMSFa)
NLP-14 (ALDGLDGSGFGFD)
a, amidated, p, pyroglutamic acid.
From Ringstad and Horvitz (77); Rogers et al. (78); Cohen et al. (87); Kubiak et al. (102), Mertens et al. (114); Kubiak et al. (115); Lowery et al. (116); Mertens et al.
(117); Mertens et al. (118); Janssen et al. (119); Kubiak et al. (120); Larsen et al. (121).
DIVERSITY OF FLPs IN NEMATODES
The accessibility of C. elegans, ease of manipulation and main-
tenance in the laboratory, and wealth of previous research have
made C. elegans a useful model in the study of FLPs in other nema-
todes, and, in particular, parasitic nematodes. Parasitic nematodes
infect over 1 billion people worldwide (University of Cambridge)
and contributes to greater than $126 billion of crop damage glob-
ally (122). The recent sequencing of multiple nematode genomes
and transcriptomes has greatly enhanced our understanding of the
FLP complement in different nematodes. In addition to C. elegans,
there are now 16 nematode genomes and/or transcriptomes that
have been completed, although some are not as well annotated as
others; this collection includes both parasitic and non-parasitic
nematodes2 . Other nematode sequences have also been deposited
in the NCBI database, allowing us to use bioinformatic techniques
to scan for flp genes among these genomes. By comparison to
the C. elegans flp genes, there are 30 parasitic and 6 free-living
nematodes that have flp orthologs [(123); unpubl. obs.].
Some striking observations can be noted among this collection
of sequences. First, most nematodes, including free-living and par-
asitic (animal and plant), have a large complement of flp genes
(Table 5). The most frequently appearing genes (>65%) among
the scanned genomes are flp-1, 11, 14, and 18; other common
genes (>50%) include flp-6, 12, 13, 16, 19, 21, 22, and 24. There
were also some genes that appear infrequently. For instance, flp-10
has only been identified in free-living nematodes (both hermaph-
rodite and male/female species), whereas, flp-31 only appears in
plant parasitic nematodes (123). Among the nematodes whose
genomes have been completely determined, free-living and ani-
mal parasitic nematodes express flp-8, 15, 23, 24, and 33; none of
the plant parasitic nematodes have been found to express these flp
genes thus far. By contrast, we have not identified any flp gene that
is expressed in free-living and plant parasitic nematodes, but not in
animal parasitic nematodes. Some flp genes appear in free-living
and parasitic nematodes, but are poorly represented, appearing
in <25% of the genomes scanned (e.g., flp-9, 26, and 28). As the
genomes/transcriptomes become better annotated, these numbers
may change. However, the diversity and number of FLPs suggest
that FLPs are widely used as neuromodulators in many, if not all,
nematodes.
2http://www.nematodes.org
FUNCTION OF FLPs IN NON-C. ELEGANS NEMATODES
Because of the difficulty of propagating some of the parasitic
nematodes in the lab, the function of peptides has been difficult to
query. Furthermore, many genetic tools, such as isolating mutants
or generating transgenic strains, are not available. However, the
larger sizes of some nematodes allow the ability to do dissections
and perform electrophysiological recordings and in situ hybridiza-
tion techniques (128–130). Hence, the flp expression patterns
described in many pathogenic nematodes based on in situ data
may more accurately reflect the expression patterns of the genes
than in C. elegans, where expression patterns are generally deter-
mined by use of transcriptional reporters (12). In addition, while
the decreased expression of the SID-1 receptor in neurons hampers
analysis of neuropeptides in C. elegans (131, 132), RNAi by soak-
ing has been effective in neurons of some pathogenic nematodes
(133). However, as in C. elegans, there are many caveats with the
use of RNAi, particularly as there are no mutants among parasitic
nematodes that can be used to confirm RNAi phenotypes (134).
For simplicity in the discussion below, any C. elegans FLP peptide
that is identical and conserved through different nematode species
will be referred to by the C. elegans name, while peptides that are
specific to a certain species will be indicated as such.
LOCOMOTION
The neuromuscular system is highly sensitive to disruptions in
FLP peptide levels. In a sand column motility assay, knockdown
of Gp-flp-1 and 18 and flp-6, 12, and 14 inhibited motility of
second-stage juvenile (J2) Globodera pallida animals by 70–100%
after 24 h of dsRNA soaking; the effects were transitory and by
6 days post-treatment, 27.1% of the animals recovered 39.4%
of their normal activity (133). By contrast, when Gp-flp-32 was
knocked down, G. pallida and Meloidogyne incognita juveniles
became more mobile, which translated to an enhanced ability to
infect potato plant and other plant roots (135).
CHEMOSENSATION
When infecting the roots of tomato plants, RNAi knockdown of
Mi-flp-18 in J2 M. incognita dramatically decreased chemotaxis
to tomato plant roots, thereby decreasing rates of infection
(136). The exudate of Chrysanthemum coronarium, which is
often planted with tomato, contains lauric acid, which decreases
Mi-flp-18 expression, hence providing a mechanism to alleviate
crop damage (136).
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Table 5 | FLP diversity in nematodes.
PHARMACOLOGY OF FLPs
Muscle preparations of some of the larger nematodes have allowed
the pharmacological application of different FLPs at nanomolar
to micromolar concentrations. For instance, Ascaris suum somatic
muscle strips can be isolated, muscle tension recorded, and the
effects of different FLPs examined (126). As-FLP-18 (0.1µM)
caused contraction and occasionally rhythmic activity; this action
could be reversed by FLP-1 (SADPNFLRF-NH2; 0.1µM) (137).
As-FLP-1, FLP-1 (SADPNFLRF-NH2, SDPNFLRF-NH2; 1 nM),
FLP-13 (APEASPFIRF-NH2;10µM) caused relaxation of mus-
cle strips whether innervated or denervated (16, 138). Further-
more, As-FLP-1 (1 nM) inhibited contractions of spontaneously
active preparations (138) and hyperpolarized muscle membrane
(139). Some of the FLPs had more complex actions and produced
biphasic responses. FLP-8 (0.1–1µM) and FLP-14 initially caused
relaxation, followed by rhythmic contractions; FLP-14 (nanomo-
lar) was 10–100 times more potent on the muscle strips than
FLP-8 (138, 140). FLP-6 (0.1–10µM) caused a rapid (within 30 s)
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increase in muscle tension in ventral muscle strips, but relax-
ation of dorsal muscle strips (126, 138). Intracellular recordings
from A. suum muscle support the effects of some FLPs on muscle
strips. Namely, FLP-1 (SDPNFLRF-NH2 and SADPNFLRF-NH2;
EC50 ~300 nM) caused a slow hyperpolarization and decreased
amplitude of the excitatory junction potentials (141).
The reproductive system of A. suum also provides a robust
biological system to examine the activity of multiple FLPs.
In particular, the ovijector contains circular muscle that reg-
ulates egg release and sperm influx; the muscle is innervated
by a nerve plexus, which is FMRFamide-like immunoreactive
(142). When the ovijector was hooked to a photo-optic trans-
ducer, the ovipositor revealed rhythmic spontaneous contrac-
tions (143). Most FLPs induced an inhibitory response, whereby
there was a decrease in contraction frequency and amplitude;
these peptides included FLP-3 (SPLGTMRF-NH2; 0.1–10µM), 4
(ASPSFIRF-NH2; 0.01µM), 7 (SPMERSAMVRF-NH2; 0.1µM),
10 (QPKARSGYIRF-NH2; 1µM), 11 (NGAPQPFVRF-NH2;
1µM), 12 (1µM), 13 (ASSAPLIRF-NH2; 1µM), 15 (GPSGPLRF-
NH2; 0.1µM), FLP-16 (GQTFVRF-NH2; 0.1µM), 17 (KSQYIRF-
NH2; 0.1µM), and 20 (AMMRF-NH2; 10µM) (143). A few
FLPs caused an excitatory response [FLP-2 (SPREPIRF-NH2; 10–
100 nM), 18 (SVPGVLRF-NH2; 10 nM–10µM), 19 (WANQVRF-
NH2; 10 nM–10µM; ASWASSVRF-NH2; 10µM), and 21 (1–
10µM)] or showed a shortening of the ovipositor before an
increase in contraction frequency [FLP-11 (AMRNALVRF-NH2;
100 nM)] (143). The activities of some peptides were only a
transient contraction [FLP-2 (LRGEPIRF-NH2; 0.1–10µM)] or
a transient contraction followed by an extended period of inac-
tivity [FLP-5 (AGAKFIRF-NH2, APKPKFIRF-NH2), 8, and 22
(SPSAKWMRF-NH2)] (143). Whether these FLP responses are
physiological are unclear, particularly as some activities were only
induced at high, micromolar concentrations.
To determine the effect of peptides in intact animals, pep-
tides were directly injected into the Ascaris pseudocelom (injected
at 100µM; final concentration within pseudocelom estimated at
10µM). FLP-8 and 14 inhibited locomotion, caused shallower
waveforms with no propagation, and shortened body length,
while injection of FLP-4 (ASPSFIRF-NH2), 6 (KSAYMRF-
NH2), 7 (SPMQRSMVRF-NH2), 13 (APEASPIRF-NH2), and
16 (AQTFVRF-NH2) and AsFLP-13 abolished body waves and
increased body length; As-FLP-1 produced a more severe phe-
notype by causing a complete paralysis (144, 145). By contrast,
injection of As-FLP-18 increased the number of body waves, but
the body waves did not propagate and body length was decreased
(145). FLP-6 and 9 caused ventral coils, while FLP-12 caused
uncoordination (145).
PHYSIOLOGY OF FLP PEPTIDES ON A. SUUM MOTONEURONS
Several FLPs are expressed in the motoneurons of many nema-
todes. A. suum presents a relatively accessible system in which
DE2 excitatory and DI inhibitory motoneurons can be exposed
in situ and recorded while saline containing test solutions (gener-
ally 10µM except where noted) are superfused; recorded responses
can be direct actions of peptides on motoneurons or indirect
effects via presynaptic neurons (128, 146). FLP-8 (1–100 nM)
abolished slow oscillatory membrane potentials and reduced input
resistances (147). As-FLP-4 and FLP-8 induced strong depolar-
izations in DE2 and weak depolarizations in DI motoneurons
and generally decreased input resistances; FLP-16 elicited strong
depolarizations in DE2 and DI (144). FLP-14 induced a stronger
depolarization, but showed a transient increase in input resistance
followed by a longer decreased input resistance in DE2 neurons;
although FLP-14 caused a modest decrease in the input resistance
of DI motoneurons, there was no membrane potential effect (144).
The depolarizations elicited by the FLPs were in many cases the
result of increased frequency of EPSPs. FLP-21 caused a complex
response in which there was an initial hyperpolarization, followed
by a sustained depolarization in DE2 neurons, but only a hyper-
polarization in DI neurons; no change or a decrease was seen in
the input resistance of DE2 and DI neurons, respectively. Appli-
cation of different As-FLP-18 peptides or As-FLP-1 elicited weak
depolarizations in DE2. FLP-6 elicited a weak hyperpolarization in
DE2, but a strong depolarization, followed by miniature IPSPs in
DI (144). As-FLP-13 elicited weak hyperpolarizations in DE2 and
DI motoneurons. No effect was seen with application of As-FLP-
28 in DE2 or DI neurons. As seen in other Ascaris preparations,
FLPs exert a diversity of effects, but the physiological relevance has
yet to be determined.
SUMMARY
The diversity and plethora of neuropeptides that can act over long
distances allows invertebrates to greatly increase the complexity
of their neural networks despite the relatively small number of
neurons. A single neuron may mediate response to several sensory
modalities and activate different or conserved downstream path-
ways to ensure correct motor outputs. Despite the relatively simple
nervous system of C. elegans, the clever use of neuropeptides, gap
junctions, hub neurons, and conventional synaptic connections
allows the animal to have a wide behavioral repertoire that can be
finely tuned in response to different environmental stimuli. Under-
standing how these simple neural networks determine behavior
remains the challenge for the future.
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